24 October 2024 -- Laupheim, Germany -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), today announced the construction of a new state-of-the-art buffer media station at its company headquarters in Laupheim.
LASER COMPONENTS offers a comprehensive range of sources and detectors for medical applications, from advanced imaging to laser surgery. Light plays an extremely important role in all aspects of medicine. Looking beyond the visible spectrum, infrared can also play an important role, measuring the things we cannot see with the human eye.
17 October 2024 -- Manchester, UK -- Yourgene Health, a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay. The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment.
11 October 2024 -- London, UK -- Serac Imaging Systems Limited announces that its clinical partner, the University of Malaya Medical Centre, has today presented initial findings and images acquired using Seracam® for image guided surgery in a sentinel lymph node biopsy procedure at the International Conference on Hybrid Imaging (IPET 2024) organised by the International Atomic Energy Agency (IAEA).
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
9 October 2024 — Noáin, Spain — 3PBIOVIAN, a leading contract development and manufacturing organization (CDMO), announces the appointment of Almira Bartolomé as Business Development Director for Advanced Therapies, reporting to Elena Erroba, Chief Commercial Officer of 3PBIOVIAN.
8 October 2024 -- Ohio, US -- ABITEC Corporation, a global leader in specialty lipid manufacturing, has expanded its custom synthesis capabilities to include high-purity lipids for lipid nanoparticle (LNP) therapeutics.
8 October 2024 -- California, US -- Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, today announced the launch of the Vericheck ddPCR™ Empty-Full Capsid Kit for the determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) AAV samples.
7 October 2024 -- Rome, Italy -- CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the initiation of a collaboration with Leica Microsystems, a leading provider of microscopy and scientific instrumentation.
3 October 2024 -- Saint-Prex, Switzerland -- Ferring Pharmaceuticals today announced the opening of a state-of-the-art global manufacturing hub in Finland for the drug substance of its intravesical non-replicating gene therapy Adstiladrin (nadofaragene firadenovec-vncg).
3 October 2024 -- Cramlington, UK -- Sterling Pharma Solutions, a global contract development and manufacturing organisation, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialisation of products to treat rare diseases where there is an unmet medical need, today announced a partnership that will see Sterling manufacture a GMP-quality synthetic hypericin developed by Soligenix, for its oncology drug, HyBryte™, in clinical trials.
Samedan announces that on 23-24 October 2024, their FlyPharma Conference will make a welcome return to Office Park 4, Vienna AirportCity, Austria.